QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
NASDAQ:HSIC

Henry Schein - HSIC Stock Forecast, Price & News

$86.74
-0.40 (-0.46%)
(As of 02/8/2023 12:00 AM ET)
Add
Compare
Today's Range
$86.09
$87.65
50-Day Range
$79.46
$89.08
52-Week Range
$64.75
$92.68
Volume
538,141 shs
Average Volume
861,386 shs
Market Capitalization
$11.76 billion
P/E Ratio
18.86
Dividend Yield
N/A
Price Target
$85.78

Henry Schein MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
1.1% Downside
$85.78 Price Target
Short Interest
Bearish
3.93% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.42
Upright™ Environmental Score
News Sentiment
1.27mentions of Henry Schein in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$6.19 M Sold Last Quarter
Proj. Earnings Growth
2.91%
From $4.81 to $4.95 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.74 out of 5 stars

Medical Sector

799th out of 1,026 stocks

Medical & Hospital Equipment Industry

2nd out of 3 stocks

HSIC stock logo

About Henry Schein (NASDAQ:HSIC) Stock

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgicals, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial on a non-recourse basis, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Stock News Headlines

Henry Schein (NASDAQ:HSIC) PT Raised to $97.00
Free Stock Analysis Report: See the Right Way to Analyze Stocks
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. pixel
Henry Schein to Host 2023 Investor Meeting
HSIC.MW - | Stock Price & Latest News | Reuters
Why savvy Investors Are Looking Beyond Stocks Right Now.
Top equity research shops like Goldman Sachs are forecasting equity returns of only 4% in the next 5 years. One place investors are turning for diversification is the art market. It has a near-zero correlation to traditional assets, meaning when the stock market declines, art investments may not be affected.  With Masterworks, it's easy for anyone to invest in art. **See important disclosures pixel
Henry Schein (HSIC) Expands Dental Offerings With New Pact
When Should You Buy Henry Schein, Inc. (NASDAQ:HSIC)?
Henry Schein's (HSIC) New Deal to Improve Patient Outcome
See More Headlines
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Company Calendar

Last Earnings
11/02/2021
Today
2/08/2023
Next Earnings (Confirmed)
2/16/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Sector
Medical
Current Symbol
NASDAQ:HSIC
CUSIP
80640710
Employees
21,600
Year Founded
1932

Price Target and Rating

Average Stock Price Forecast
$85.78
High Stock Price Forecast
$99.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
-1.1%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
8 Analysts

Profitability

Net Income
$631.23 million
Pretax Margin
6.75%

Debt

Sales & Book Value

Annual Sales
$12.40 billion
Cash Flow
$6.16 per share
Book Value
$29.30 per share

Miscellaneous

Free Float
134,193,000
Market Cap
$11.76 billion
Optionable
Optionable
Beta
0.82

Social Links


Key Executives

  • Stanley M. BergmanStanley M. Bergman
    Chairman & Chief Executive Officer
  • James P. BreslawskiJames P. Breslawski
    Vice Chairman & President
  • Ronald N. South
    Senior VP, Chief Financial & Accounting Officer
  • Christopher Pendergast
    Chief Technology Officer & Senior Vice President
  • Mark E. MlotekMark E. Mlotek
    Director, Chief Strategic Officer & Executive VP













HSIC Stock - Frequently Asked Questions

Should I buy or sell Henry Schein stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HSIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View HSIC analyst ratings
or view top-rated stocks.

What is Henry Schein's stock price forecast for 2023?

8 equities research analysts have issued 12 month price targets for Henry Schein's stock. Their HSIC share price forecasts range from $70.00 to $99.00. On average, they anticipate the company's stock price to reach $85.78 in the next year. This suggests that the stock has a possible downside of 1.1%.
View analysts price targets for HSIC
or view top-rated stocks among Wall Street analysts.

How have HSIC shares performed in 2023?

Henry Schein's stock was trading at $79.87 at the beginning of the year. Since then, HSIC stock has increased by 8.6% and is now trading at $86.74.
View the best growth stocks for 2023 here
.

When is Henry Schein's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our HSIC earnings forecast
.

How can I listen to Henry Schein's earnings call?

Henry Schein will be holding an earnings conference call on Thursday, February 16th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 877-660-6853 with passcode "13734321".

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) posted its earnings results on Tuesday, November, 2nd. The company reported $1.10 EPS for the quarter, beating analysts' consensus estimates of $0.94 by $0.16. The company had revenue of $3.18 billion for the quarter, compared to the consensus estimate of $2.94 billion. Henry Schein had a trailing twelve-month return on equity of 15.48% and a net margin of 5.06%. During the same period last year, the business posted $1.03 EPS.
Read the conference call transcript
.

When did Henry Schein's stock split?

Henry Schein shares split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were payable to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein announced that its Board of Directors has initiated a share repurchase program on Thursday, August 18th 2022, which permits the company to repurchase $400,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to purchase up to 4% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's management believes its stock is undervalued.

What is Stanley M. Bergman's approval rating as Henry Schein's CEO?

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a variety of retail and institutional investors. Top institutional investors include Pendal Group Ltd (3.09%), California Public Employees Retirement System (0.70%), DekaBank Deutsche Girozentrale (0.68%), New York State Common Retirement Fund (0.67%), Ardevora Asset Management LLP (0.45%) and Boston Trust Walden Corp (0.41%). Insiders that own company stock include Bradford C Connett, Deborah Derby, Gerald A Benjamin, James P Breslawski, James P Breslawski, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael S Ettinger, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends
.

How do I buy shares of Henry Schein?

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $86.74.

How much money does Henry Schein make?

Henry Schein (NASDAQ:HSIC) has a market capitalization of $11.76 billion and generates $12.40 billion in revenue each year. The company earns $631.23 million in net income (profit) each year or $4.60 on an earnings per share basis.

How many employees does Henry Schein have?

The company employs 21,600 workers across the globe.

Does Henry Schein have any subsidiaries?
The following companies are subsidiares of Henry Schein: ACE Surgical Supply Co. Inc., ADS Florida, AUV Veterinary Services, Accord, Alpha Scientific, Arcade Dentaire, Arseus, Arseus Dental Solutions, Arseus Lab, Becker-Parkin Dental Supply, BioHorizons Inc., Butler Schein Animal Health, C&M Vetlink, Camlog USA Inc., DNA Anthos Impianti, Dental Cremer, Dental Trey, Elite Computer Italia, Exan Enterprises Inc., HS Brand Management LLC, HS TM Holdings LLC, HSFR Inc., Handpiece Parts & Repairs Inc., Henry Schein Europe Inc., Henry Schein Global Sourcing Inc., Henry Schein Latin America Pacific Rim Inc., Henry Schein Medical Systems Inc., Henry Schein Practice Solutions Inc., InSource Inc., Jorgen Kruuse, Lincoln Dental Supply, Logiciel Julie, Maddox Practice Group, Maravet, Marrodent, Medivet, Medka, Minerva Dental Limited, Modern Laboratory Services, NLS Animal Health, Noviko, Ortho Organizers, Ortho Technology, Prism Medical Products L.L.C., Prism Medical Products LLC, Project Helium Holdings LLC, Project Spartan Holdings Corp., RxWorks, SG Healthcare Corp., Sirona Direct, SmartPak Equine LLC, Software of Excellence, Sogim Grimouille, Southern Anesthesia & Surgical, S & S Discount Inc., TDSC Inc., The Exan Group, Veterinary Instrumentation, Vetstreet, W. & J. Dunlop, eAssist Inc., and scil animal care.
Read More
How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The official website for the company is www.henryschein.com. The company can be reached via phone at (631) 843-5500, via email at steven.paladino@henryschein.com, or via fax at 631-843-5541.

This page (NASDAQ:HSIC) was last updated on 2/8/2023 by MarketBeat.com Staff